Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

By Marleen Kaesebier BASEL, Switzerland, May 5 (Reuters) - Switzerland's biotech industry shifted toward private financing in 2025 as funding from capital markets remained difficult to obtain and ...

A cross-section of biotech leaders is launching the American Biotech Innovation Alliance (ABIA) with the goal of uniting ...

Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first ...

Artificial intelligence has dominated investor attention for two years, but biotech revenue lines are also bending sharply ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Sellas Life Sciences CEO Angelos Stergiou met with European lawmakers to discuss the EU Biotech Act and drug approval processes, calling the talks 'exceptionally constructive.' The engagement comes as ...

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...